SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '5t2o'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZ1_A_HLTA2001_1
(FERRITIN LIGHT CHAIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 4 LEU A 215
SER A 214
TYR A 218
LEU A 219
None
1.18A 1xz1A-5t2oA:
undetectable
1xz1A-5t2oA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1XZ3_A_ICFA201_1
(FERRITIN LIGHT CHAIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 4 LEU A 215
SER A 214
TYR A 218
LEU A 219
None
1.17A 1xz3A-5t2oA:
undetectable
1xz3A-5t2oA:
22.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VXA_A_RBFA200_1
(DODECIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 8 ARG A 232
TRP A 234
HIS A 205
GLN A 204
None
None
None
CA  A 401 ( 4.2A)
1.49A 2vxaA-5t2oA:
undetectable
2vxaC-5t2oA:
undetectable
2vxaE-5t2oA:
undetectable
2vxaA-5t2oA:
13.54
2vxaC-5t2oA:
13.54
2vxaE-5t2oA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VXA_B_RBFB200_1
(DODECIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 8 ARG A 232
TRP A 234
HIS A 205
GLN A 204
None
None
None
CA  A 401 ( 4.2A)
1.49A 2vxaA-5t2oA:
undetectable
2vxaB-5t2oA:
undetectable
2vxaK-5t2oA:
undetectable
2vxaA-5t2oA:
13.54
2vxaB-5t2oA:
13.54
2vxaK-5t2oA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2VXA_E_RBFE200_1
(DODECIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 8 ARG A 232
TRP A 234
HIS A 205
GLN A 204
None
None
None
CA  A 401 ( 4.2A)
1.50A 2vxaD-5t2oA:
undetectable
2vxaE-5t2oA:
undetectable
2vxaL-5t2oA:
undetectable
2vxaD-5t2oA:
13.54
2vxaE-5t2oA:
13.54
2vxaL-5t2oA:
13.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_A_SAMA300_0
(PUTATIVE RRNA
METHYLASE)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 12 ASN A 228
ILE A 202
GLY A 179
LEU A 235
THR A 238
None
1.08A 3eeyA-5t2oA:
undetectable
3eeyA-5t2oA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_B_SAMB300_0
(PUTATIVE RRNA
METHYLASE)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 12 ASN A 228
ILE A 202
GLY A 179
LEU A 235
THR A 238
None
1.05A 3eeyB-5t2oA:
undetectable
3eeyB-5t2oA:
21.12
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3GLQ_A_RABA602_1
(ADENOSYLHOMOCYSTEINA
SE)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 12 LEU A 258
THR A 175
LEU A 168
LEU A 171
PHE A 181
None
1.42A 3glqA-5t2oA:
undetectable
3glqA-5t2oA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3N58_D_ADND500_1
(ADENOSYLHOMOCYSTEINA
SE)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 12 LEU A 258
THR A 175
LEU A 168
LEU A 171
PHE A 181
None
1.45A 3n58D-5t2oA:
undetectable
3n58D-5t2oA:
20.56
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3SUD_B_SUEB1201_1
(NS3 PROTEASE, NS4A
PROTEIN)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 12 PHE A  18
ILE A 165
GLY A  17
ALA A  21
SER A 214
None
None
None
CA  A 401 (-4.8A)
None
1.10A 3sudB-5t2oA:
undetectable
3sudB-5t2oA:
22.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3Z_A_9PLA501_1
(CYTOCHROME P450 2E1)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 6 LEU A  15
PHE A  45
ALA A  46
LEU A  57
None
0.97A 3t3zA-5t2oA:
undetectable
3t3zA-5t2oA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3Z_B_9PLB501_1
(CYTOCHROME P450 2E1)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 6 LEU A  15
PHE A  45
ALA A  46
LEU A  57
None
0.95A 3t3zB-5t2oA:
undetectable
3t3zB-5t2oA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3T3Z_D_9PLD501_1
(CYTOCHROME P450 2E1)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
4 / 6 LEU A  15
PHE A  45
ALA A  46
LEU A  57
None
0.96A 3t3zD-5t2oA:
undetectable
3t3zD-5t2oA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4DRH_D_RAPD201_2
(PEPTIDYL-PROLYL
CIS-TRANS ISOMERASE
FKBP5
SERINE/THREONINE-PRO
TEIN KINASE MTOR)
5t2o I-ONUI_E-AG011377
(synthetic
construct)
5 / 9 LEU A  49
ARG A  80
PHE A  45
THR A  16
ASP A  20
None
1.30A 4drhE-5t2oA:
3.0
4drhE-5t2oA:
15.75